Divi's Laboratories Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-04-21 | -1,059.93 | +2,966.89 |
| 2026-04-20 | +683.2 | -4,721.48 |
| 2026-04-18 | +683.2 | -4,721.48 |
Today's Institutional Flow
Foreign Institutional Investors (FII) sold ₹1,059.93 Cr in cash today, reflecting risk-off sentiment in pharma. Domestic Institutional Investors (DII) countered with strong buying of ₹2,966.89 Cr, signaling confidence amid correction. Cash market flows show a sharp divergence between foreign and local sentiment.
Trend vs 5-Day Average
Today’s FII selling is below their 5-day average inflow of ₹683.2 Cr, marking a sharp reversal in foreign participation. DII buying stands in stark contrast to their 5-day average outflow of ₹4,721.48 Cr, indicating a potential turning point in domestic ownership.
F&O Positioning Signal
FII F&O cash stood flat at ₹0 Cr, showing no derivative-based directional bets. The Index Futures Long/Short ratio at 1.2 suggests mild bullish bias at the aggregate level, though not extended into Divis's Laboratories Limited.
Implication for Finance
Persistent DII accumulation amid FII profit-taking may support pharma sector resilience and limit downside for Divis's Laboratories Limited tomorrow.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21